CEO of Arcus Biosciences Inc (RCUS, Financial) Terry J Rosen bought 21,738 shares of RCUS on 06/06/2019 at an average price of $7.93 a share. The total cost of this purchase was $172,382.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies. Arcus Biosciences Inc has a market cap of $366.520 million; its shares were traded at around $8.23 with and P/S ratio of 39.96.
CEO Recent Trades:
- CEO Terry J Rosen bought 21,738 shares of RCUS stock on 06/06/2019 at the average price of $7.93. The price of the stock has increased by 3.78% since.
- CEO Terry J Rosen bought 41,540 shares of RCUS stock on 06/04/2019 at the average price of $7.91. The price of the stock has increased by 4.05% since.
Directors and Officers Recent Trades:
- President Juan C. Jaen bought 10,000 shares of RCUS stock on 06/03/2019 at the average price of $8.25. The price of the stock has decreased by 0.24% since.
For the complete insider trading history of RCUS, click here
.
